Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Viscido

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Medicina (Kaunas, Lithuania)|October 28, 2023
COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical ManifestationsFilippo Vernia, Hassan Ashktorab, Nicola Cesaro, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 11, 2008
Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapyValeria D'Ovidio, Piero Vernia, Giuseppe Gentile, et al.
Digestion|June 6, 2015
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related SymptomsAnnalisa Capannolo, Angelo Viscido, Mohamed Ali Barkad, et al.
Radiology|December 24, 2005
MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agentFrancesca Maccioni, Antonio Bruni, Angelo Viscido, et al.
European Journal of Gastroenterology & Hepatology|September 18, 2024
The role of new inflammatory indices in the prediction of endoscopic and histological activity in inflammatory bowel disease patientsNicola Cesaro, Marco Valvano, Sabrina Monaco, et al.
Clinical Chemistry and Laboratory Medicine|November 24, 2004
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidenceMarco Di Tola, Luigi Sabbatella, Maria Cristina Anania, et al.
Autoimmunity Reviews|September 7, 2023
SpA plus IBD or IBD plus SpA: Does commutative property apply?Francesco Carubbi, Alessia Alunno, Angelo Viscido, et al.
The American Journal of Gastroenterology|May 17, 2002
GI distension in severe ulcerative colitisGiovanni Latella, Piero Vernia, Angelo Viscido, et al.
BMC Gastroenterology|March 4, 2022
Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitisAngelo Viscido, Marco Valvano, Gianpiero Stefanelli, et al.
Journal of Clinical Medicine|May 13, 2023
Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn's PatientsGiuseppe Frieri, Marco Valvano, Sara Frassino, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Medicina (Kaunas, Lithuania)|October 28, 2023
COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical ManifestationsFilippo Vernia, Hassan Ashktorab, Nicola Cesaro, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 11, 2008
Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapyValeria D'Ovidio, Piero Vernia, Giuseppe Gentile, et al.
Digestion|June 6, 2015
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related SymptomsAnnalisa Capannolo, Angelo Viscido, Mohamed Ali Barkad, et al.
Radiology|December 24, 2005
MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agentFrancesca Maccioni, Antonio Bruni, Angelo Viscido, et al.
European Journal of Gastroenterology & Hepatology|September 18, 2024
The role of new inflammatory indices in the prediction of endoscopic and histological activity in inflammatory bowel disease patientsNicola Cesaro, Marco Valvano, Sabrina Monaco, et al.
Clinical Chemistry and Laboratory Medicine|November 24, 2004
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidenceMarco Di Tola, Luigi Sabbatella, Maria Cristina Anania, et al.
Autoimmunity Reviews|September 7, 2023
SpA plus IBD or IBD plus SpA: Does commutative property apply?Francesco Carubbi, Alessia Alunno, Angelo Viscido, et al.
The American Journal of Gastroenterology|May 17, 2002
GI distension in severe ulcerative colitisGiovanni Latella, Piero Vernia, Angelo Viscido, et al.
BMC Gastroenterology|March 4, 2022
Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitisAngelo Viscido, Marco Valvano, Gianpiero Stefanelli, et al.
Journal of Clinical Medicine|May 13, 2023
Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn's PatientsGiuseppe Frieri, Marco Valvano, Sara Frassino, et al.
Pageof 8